IMMUNOGEN INCIMMUNOGEN INCIMMUNOGEN INC

IMMUNOGEN INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
−0.28EUR
‪−208.30 M‬EUR
‪101.64 M‬EUR
Beta (1Y)
0.97

About IMMUNOGEN INC

Headquarters
Waltham
Employees (FY)
277
Founded
1981
ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of IMU is 29.00 EUR — it has increased by 0.17% in the past 24 hours. Watch IMMUNOGEN INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange IMMUNOGEN INC stocks are traded under the ticker IMU.
IMMUNOGEN INC is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
IMU stock is 0.31% volatile and has beta coefficient of 0.97. Track IMMUNOGEN INC stock price on the chart and check out the list of the most volatile stocks — is IMMUNOGEN INC there?
IMU earnings for the last quarter are 0.19 EUR per share, whereas the estimation was 0.12 EUR resulting in a 62.30% surprise. The estimated earnings for the next quarter are 0.06 EUR per share. See more details about IMMUNOGEN INC earnings.
IMMUNOGEN INC revenue for the last quarter amounts to ‪123.04 M‬ EUR despite the estimated figure of ‪117.30 M‬ EUR. In the next quarter revenue is expected to reach ‪109.32 M‬ EUR.
Yes, you can track IMMUNOGEN INC financials in yearly and quarterly reports right on TradingView.
IMU net income for the last quarter is ‪29.09 M‬ EUR, while the quarter before that showed ‪−3.89 M‬ EUR of net income which accounts for 846.86% change. Track more IMMUNOGEN INC financial stats to get the full picture.
No, IMU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IMU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMUNOGEN INC stock right from TradingView charts — choose your broker and connect to your account.
IMU reached its all-time high on Feb 8, 2024 with the price of 29.08 EUR, and its all-time low was 1.41 EUR and was reached on Nov 4, 2016. View more price dynamics on IMU chart.
See other stocks reaching their highest and lowest prices.
As of May 7, 2024, the company has 277.00 employees. See our rating of the largest employees — is IMMUNOGEN INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMMUNOGEN INC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMMUNOGEN INC stock shows the buy signal. See more of IMMUNOGEN INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on IMMUNOGEN INC future price: according to them, IMU price has a max estimate of 28.34 EUR and a min estimate of 28.34 EUR. Watch IMU chart and read a more detailed IMMUNOGEN INC stock forecast: see what analysts think of IMMUNOGEN INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMMUNOGEN INC EBITDA is ‪−74.22 M‬ EUR, and current EBITDA margin is −201.42%. See more stats in IMMUNOGEN INC financial statements.